EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 4 (Avril 2004) Med Sci (Paris), 20 4 (2004) 409-413 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 4, Avril 2004
Page(s) 409 - 413
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004204409
Published online 15 April 2004
  1. Goldblatt H. The renal origin of hypertension. Physiol Rev 1947; 27 : 120–65. [Google Scholar]
  2. van Kesteren CA, Danser AH, Derkx FH, et al. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 1997; 30 : 1389–96. [Google Scholar]
  3. de Lannoy LM, Danser AH, van Kats JP, et al. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension 1997; 29 : 1240–51. [Google Scholar]
  4. Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109 : 1417–27. [Google Scholar]
  5. Coulet F, Gonzalez W, Boixel C, et al. Endothelium-independent conversion of angiotensin I by vascular smooth muscle cells. Cell Tissue Res 2001; 303 : 227–34. [Google Scholar]
  6. Levy BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease ? Implications for therapeutic blockade of the renin-angiotensin system. Circulation 2004; 109 : 8–13. [Google Scholar]
  7. Pueyo ME, N’Diaye N, Michel JB. Angiotensin II-elicited signal transduction via AT1 receptors in endothelial cells. Br J Pharmacol 1996; 118 : 79–84. [Google Scholar]
  8. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle : role of tyrosine kinases. Circ Res 1997; 80 : 607–16. [Google Scholar]
  9. Weigert C, Brodbeck K, Klopfer K, et al. Angiotensin II induces human TGF-beta 1 promoter activation : similarity to hyperglycaemia. Diabetologia 2002; 45 : 890–8. [Google Scholar]
  10. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000; 91 : 21–7. [Google Scholar]
  11. Pagano PJ, Chanock SJ, Siwik DA, et al. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 1998; 32 : 331–7. [Google Scholar]
  12. Kranzhofer R, Schmidt J, Pfeiffer CA, et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19 : 1623–9. [Google Scholar]
  13. Brown NJ, Vaughan DE. Prothrombotic effects of angiotensin. Adv Intern Med 2000; 45 : 419–29. [Google Scholar]
  14. Pueyo ME, Gonzalez W, Nicoletti A, et al. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20 : 645–51. [Google Scholar]
  15. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts : response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26 : 809–20. [Google Scholar]
  16. Brown NJ, Kumar S, Painter CA, Vaughan DE. ACE inhibition versus angiotensin type 1 receptor antagonism : differential effects on PAI-1 over time. Hypertension 2002; 40 : 859–65. [Google Scholar]
  17. Henrion D, Dowell FJ, Levy BI, Michel JB. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension 1996; 28 : 361–6. [Google Scholar]
  18. Pagano PJ, Clark JK, Cifuentes-Pagano ME, et al. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia : enhancement by angiotensin II. Proc Natl Acad Sci USA 1997; 94 : 14483–8. [Google Scholar]
  19. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345 : 851–60. [Google Scholar]
  20. Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345 : 870–8. [Google Scholar]
  21. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes : génétique de la néphropathie diabétique (GENEDIAB) study group. J Clin Invest 1997; 99 : 1585–95. [Google Scholar]
  22. Pueyo ME, Challah, M, Gaugier, D, et al. TGF-béta1 production is correlated with genetically determined angiotensin-converting enzyme expression in congenic rats. Diabetes 2004 (sous presse). [Google Scholar]
  23. Yamada H, Fabris B, Allen AM, et al. Localization of angiotensin converting enzyme in rat heart. Circ Res 1991; 68 : 141–9. [Google Scholar]
  24. Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002; 106 : 2224–30. [Google Scholar]
  25. Johnston CI, Mooser V, Sun Y, Fabris B. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin Exp Pharmacol Physiol 1991; 18 : 107–10. [Google Scholar]
  26. Gaertner R, Prunier F, Philippe M, et al. Scar and pulmonary expression and shedding of ACE in rat myocardial infarction. Am J Physiol Heart Circ Physiol 2002; 283 : H156–64. [Google Scholar]
  27. Sun Y, Zhang JQ, Zhang J, Ramires FJ. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol 1998; 30 : 1559–69. [Google Scholar]
  28. Challah M, Villard E, Philippe M, et al. Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats. Arterioscler Thromb Vasc Biol 1998; 18 : 235–43. [Google Scholar]
  29. Amant C, Bauters C, Bodart JC, et al. Dallele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 1997; 96 : 56–60. [Google Scholar]
  30. Paragh G, Szabo J, Kovacs E, et al. Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolaemia. Cell Signal 2002; 14 : 787–92. [Google Scholar]
  31. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105 : 1605–12. [Google Scholar]
  32. Wang YX, Martin-McNulty B, Freay AD, et al. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 2001; 159 : 1455–64. [Google Scholar]
  33. Manning MW, Cassi LA, Huang J, et al A. Abdominal aortic aneurysms : fresh insights from a novel animal model of the disease. Vasc Med 2002; 7 : 45–54. [Google Scholar]
  34. Dol F, Martin G, Staels B, et al. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 2001; 38 : 395–405. [Google Scholar]
  35. Menard J, Campbell DJ, Azizi M, Gonzales MF. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997; 96 : 3072–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.